Multicenter study to transplant hepatitis C-infected kidneys (mythic): An open-label study of combined glecaprevir and pibrentasvir to treat recipients of transplanted kidneys from deceased donors with hepatitis c virus infection

Meghan E. Sise, David S. Goldberg, Jens J. Kort, Douglas E. Schaubel, Rita R. Alloway, Christine M. Durand, Robert J. Fontana, Robert S. Brown, John J. Friedewald, Stacey Prenner, J. Richard Landis, Melissa Fernando, Caitlin C. Phillips, E. Steve Woodle, Adele Rike-Shields, Kenneth E. Sherman, Nahel Elias, Winfred W. Williams, Jenna L. Gustafson, Niraj M. DesaiBrittany Barnaba, Silas P. Norman, Mona Doshi, Samuel T. Sultan, Meredith J. Aull, Josh Levitsky, Dianne S. Belshe, Raymond T. Chung, Peter P. Reese

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Multicenter study to transplant hepatitis C-infected kidneys (mythic): An open-label study of combined glecaprevir and pibrentasvir to treat recipients of transplanted kidneys from deceased donors with hepatitis c virus infection'. Together they form a unique fingerprint.

Medicine & Life Sciences